SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2
Frequently Asked Questions
What is Market Cap of SciSparc Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. SciSparc Ltd market cap is $2.12M.
What is the 52-week high for SciSparc Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. SciSparc Ltd 52 week high is $37.59 as of September 23, 2025.
What is the 52-week low for SciSparc Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. SciSparc Ltd 52 week low is $1.75 as of September 23, 2025.
What is SciSparc Ltd stock price today?
SciSparc Ltd stock price today is $4.13.
What was SciSparc Ltd stock price yesterday?
SciSparc Ltd stock price yesterday was $3.97.
What is the PE ratio of SciSparc Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. SciSparc Ltd’s P/E ratio is -0.10.
What is the Price-to-Book ratio of SciSparc Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. SciSparc Ltd P/B ratio is 0.2510.
What is the 50-day moving average of SciSparc Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. SciSparc Ltd 50-day moving average is $4.84.
